| 1 |
Comparison of Pharmacovigilance and Herbovigilance Regulatory Guidelines at the Global level |
|
|
| Kumari Arpana Kajal |
|
| Journal of Pharmacovigilance and Drug Research. 2023; 4(2): 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
An overview of the worldwide master key for pharmacovigilance and its role in India |
|
|
| Janmejay Pant, Harneet Marwah, Ripudaman M Singh, Subhajit Hazra |
|
| Journal of Pharmacovigilance and Drug Research. 2021; 2(2): 19 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Artificial neural network: A data mining tool in pharmacovigilance |
|
|
| B. Mamatha, P. Venkateswara Rao |
|
| Journal of Pharmacovigilance and Drug Research. 2020; 1(1): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance |
|
|
| Ram Sahu,Rajni Yadav,Pushpa Prasad,Amit Roy,Shashikant Chandrakar |
|
| SpringerPlus. 2014; 3(1): 695 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Pharmacovigilance regulations in India: A Step forward |
|
|
| Shilpi Khattri,V. Balamuralidhara,Kumar T. M. Pramod,Ravi Valluru,M. P. Venkatesh |
|
| Clinical Research and Regulatory Affairs. 2012; 29(2): 41 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Monitoring of incidence, severity, and causality of adverse drug reactions in hospitalized patients with cardiovascular disease |
|
|
| Kaur, S., Kapoor, V., Mahajan, R., Lal, M., Gupta, S. |
|
| Indian Journal of Pharmacology. 2011; 43(1): 22-26 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Overview and comparison of postmarketing drug safety surveillance in selected developing and well-developed countries |
|
|
| Vaidya, S.S., Guo, J.J., Heaton, P.C., Steinbuch, M. |
|
| Drug Information Journal. 2010; 44(5): 519-533 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Emerging trends in contract research industry in India |
|
|
| Drabu, S., Gupta, A., Bhadauria, A. |
|
| Contemporary Clinical Trials. 2010; 31(5): 419-422 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Pharmacovigilance: A worldwide master key for drug safety monitoring |
|
|
| Jeetu, G., Anusha, G. |
|
| Journal of Young Pharmacists. 2010; 2(3): 315-320 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Patterns of adrs and risk factors involved: Study in cardiology unit of an indian tertiary care center |
|
|
| Kaur, S., Kapoor, V., Mahajan, R., Lal, M., Gupta, S. |
|
| Internet Journal of Pharmacology. 2010; 8(1) |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring |
|
|
| G. Jeetu,G. Anusha |
|
| Journal of Young Pharmacists. 2010; 2(3): 315 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Pharmacovigilance in Herbal Medicine: A Paradigm to Drug Toxicity Monitoring in Conventional Health Care |
|
|
| Yousif Asiri, Abdlatif Al-Dhawailie, Saleh Alqasoumi, Mohammed Al-Yahya, Syed Rafatullah |
|
| Hungarian Medical Journal. 2008; 2(3): 351 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 13 |
Adverse drug reaction (ADR) notification drop box: An easy way to report ADRs |
|
|
| Amit, D., Rataboli, P.V. |
|
| British Journal of Clinical Pharmacology. 2008; 66(5): 723-724 |
|
| [Pubmed] [Google Scholar] |
|
| 14 |
Pharmacovigilance obligations of the pharmaceutical companies in India |
|
|
| Arora, D. |
|
| Indian Journal of Pharmacology. 2008; 40(Suppl 1): S13-S16 |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
Adverse drug reaction (ADR) notification drop box: an easy way to report ADRs |
|
|
| Dang Amit,Padmanabh V. Rataboli |
|
| British Journal of Clinical Pharmacology. 2008; : ??? |
|
| [Pubmed] [Google Scholar] [DOI] |
|
